These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7820699

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion.
    Huang SK, Pan JT.
    Neuroendocrinology; 1996 Sep; 64(3):208-14. PubMed ID: 8875438
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L.
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [Abstract] [Full Text] [Related]

  • 4. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y, Xin X, Shim GJ, Mokuno Y, Uehara H, Yamada T, Agui T, Matsumoto K.
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [Abstract] [Full Text] [Related]

  • 5. Possible involvement of vasoactive intestinal polypeptide in the central stimulating action of pituitary adenylate cyclase-activating polypeptide on prolactin secretion in the rat.
    Yamauchi K, Murakami Y, Nishiki M, Tanaka J, Koshimura K, Kato Y.
    Neurosci Lett; 1995 Apr 14; 189(2):131-4. PubMed ID: 7609919
    [Abstract] [Full Text] [Related]

  • 6. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 14; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 7. Pituitary adenylate cyclase activating polypeptide enhances rapid eye movement sleep in rats.
    Fang J, Payne L, Krueger JM.
    Brain Res; 1995 Jul 17; 686(1):23-8. PubMed ID: 7583267
    [Abstract] [Full Text] [Related]

  • 8. Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat.
    Ahnaou A, Basille M, Gonzalez B, Vaudry H, Hamon M, Adrien J, Bourgin P.
    Eur J Neurosci; 1999 Nov 17; 11(11):4051-8. PubMed ID: 10583493
    [Abstract] [Full Text] [Related]

  • 9. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on prolactin, luteinizing hormone and growth hormone secretion in the ewe.
    Sawangjaroen K, Curlewis JD.
    J Neuroendocrinol; 1994 Oct 17; 6(5):549-55. PubMed ID: 7827625
    [Abstract] [Full Text] [Related]

  • 10. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus.
    Grinevich V, Fournier A, Pelletier G.
    Brain Res; 1997 Oct 31; 773(1-2):190-6. PubMed ID: 9409720
    [Abstract] [Full Text] [Related]

  • 11. Differential alternative splicing of PACAP receptor in pituitary cell subpopulations.
    Vertongen P, Velkeniers B, Hooghe-Peters E, Robberecht P.
    Mol Cell Endocrinol; 1995 Sep 22; 113(2):131-5. PubMed ID: 8674820
    [Abstract] [Full Text] [Related]

  • 12. Prolactin, vasoactive intestinal peptide, and peptide histidine methionine elicit selective increases in REM sleep in rabbits.
    Obal F, Opp M, Cady AB, Johannsen L, Krueger JM.
    Brain Res; 1989 Jun 26; 490(2):292-300. PubMed ID: 2765864
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar 26; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 15. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on gonadotropin-releasing hormone and somatostatin gene expression in the rat brain.
    Li S, Grinevich V, Fournier A, Pelletier G.
    Brain Res Mol Brain Res; 1996 Sep 05; 41(1-2):157-62. PubMed ID: 8883947
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pituitary adenylate cyclase-activating polypeptide modulates plasminogen activator expression in rat granulosa cell.
    Apa R, Lanzone A, Miceli F, Vaccari S, Macchione E, Stefanini M, Canipari R.
    Biol Reprod; 2002 Mar 05; 66(3):830-5. PubMed ID: 11870092
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
    Matsuda K, Maruyama K, Nakamachi T, Miura T, Uchiyama M, Shioda S.
    Peptides; 2005 Sep 05; 26(9):1611-6. PubMed ID: 16112400
    [Abstract] [Full Text] [Related]

  • 19. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats.
    Murase T, Kondo K, Otake K, Oiso Y.
    Neuroendocrinology; 1993 Jun 05; 57(6):1092-6. PubMed ID: 7901784
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase-activating polypeptide (PACAP) increases prolactin release and tuberoinfundibular dopaminergic neuronal activity.
    Arbogast LA, Voogt JL.
    Brain Res; 1994 Aug 29; 655(1-2):17-24. PubMed ID: 7812770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.